Abstract

BackgroundRecurrence of Glioblastoma multiforme (GBM) seems to be the rule despite combination therapies. Cell invasion and cell proliferation are major reasons for recurrence of GBM. And insulin-like growth factor binding protein 5 (IGFBP5) is the most conserved of the IGFBPs and is frequently dysregulated in cancers and metastatic tissues.ResultsBy studying the human glioma tissues, we find that IGFBP5 expression associate to the histopathological classification and highly expressed in GBM. Using IGFBP5 mutants we demonstrate that knockdown of IGFBP5 inhibited cell invasion, whereas promoting cell proliferation in GBM cells. Mechanistically, we observed that promoting GBM cell proliferation by inhibiting IGFBP5 was associated with stimulating Akt (Protein kinase B) phosphorylation. However, IGFBP5 promote GBM cell invasion was related to the epithelial-to-mesenchymal transition (EMT). Furthermore, the Chinese Glioma Genome Altas (CGGA) database show that IGFBP5 is significantly increased in recurrent glioma and it predicted worse survival.ConclusionsThe obtained results indicate that IGFBP5 has two sides in GBM—inhibiting cell proliferation but promoting cell invasion.

Highlights

  • Recurrence of Glioblastoma multiforme (GBM) seems to be the rule despite combination therapies

  • insulin-like growth factor binding protein 5 (IGFBP5) expression was upregulated in high grade glioma In order to analyze the expression of IGFBP5 in glioma, we stained of human glioma tissues with antibodies against IGFBP5, and the results indicated that IGFBP5 clinically correlated with the progression of glioma (Fig. 1a)

  • We analyzed The Cancer Genome Atlas (TCGA) database [19] and Chinese Glioma Genome Altas (CGGA) database, similar results were obtained and found that GBM tumors with elevated expression of IGFBP5 (Fig. 1b, c). These findings suggest that IGFBP5 is positively correlated with the progression of glioma

Read more

Summary

Introduction

Recurrence of Glioblastoma multiforme (GBM) seems to be the rule despite combination therapies. Cell invasion and cell proliferation are major reasons for recurrence of GBM. Insulin-like growth factor binding protein 5 (IGFBP5) is the most conserved of the IGFBPs and is frequently dysregulated in cancers and metastatic tissues. Glioblastoma multiforme (GBM) is the most common malignant and aggressive intracranial tumor in adults [1]. The average annual age-adjusted incidence rate of GBM was about 3–5/100,000/year [2, 3]. The mean overall survival achieved with combination therapies only 14.6 months [4]. Maximal safe neurosurgical resection accompanied by radiotherapy and chemotherapy are the standard treatment for GBM [5]. Recurrence seems to be the rule despite combination therapies [6].

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call